Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19
Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
PLoS Biology (2020) Vol. 18, Iss. 11, pp. e3000970-e3000970
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Artificial intelligence in COVID-19 drug repurposing
Yadi Zhou, Fei Wang, Jian Tang, et al.
The Lancet Digital Health (2020) Vol. 2, Iss. 12, pp. e667-e676
Open Access | Times Cited: 535
Using machine learning approaches for multi-omics data analysis: A review
Parminder Singh Reel, Smarti Reel, Ewan R. Pearson, et al.
Biotechnology Advances (2021) Vol. 49, pp. 107739-107739
Open Access | Times Cited: 500
COVID-19 and Cardiovascular Disease
Mina K. Chung, David A. Zidar, Michael R. Bristow, et al.
Circulation Research (2021) Vol. 128, Iss. 8, pp. 1214-1236
Open Access | Times Cited: 346
Drug repurposing for COVID-19 via knowledge graph completion
Rui Zhang, Dimitar Hristovski, Dalton Schutte, et al.
Journal of Biomedical Informatics (2021) Vol. 115, pp. 103696-103696
Open Access | Times Cited: 160
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
Mario Gennaro Mazza, Mariagrazia Palladini, Sara Poletti, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 681-702
Open Access | Times Cited: 155
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Yadi Zhou, Jielin Xu, Yuan Hou, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 135
Deep generative molecular design reshapes drug discovery
Xiangxiang Zeng, Fei Wang, Yuan Luo, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 12, pp. 100794-100794
Open Access | Times Cited: 131
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Yan Ling Ng, Cyrill Kafi Salim, Justin Jang Hann Chu
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107930-107930
Open Access | Times Cited: 129
A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 1, pp. 128-139
Open Access | Times Cited: 124
Deep learning for drug repurposing: Methods, databases, and applications
Xiaoqin Pan, Xuan Lin, Dongsheng Cao, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 96
More is different in real-world multilayer networks
Manlio De Domenico
Nature Physics (2023) Vol. 19, Iss. 9, pp. 1247-1262
Closed Access | Times Cited: 67
Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers
Dongmin Bang, Sangsoo Lim, Sangseon Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 51
Artificial intelligence streamlines scientific discovery of drug–target interactions
Yuxin Yang, Feixiong Cheng
British Journal of Pharmacology (2025)
Open Access | Times Cited: 1
Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
Daniel P. Cardinali, Gregory M. Brown, Seithikurippu R. Pandi‐Perumal
Diseases (2020) Vol. 8, Iss. 4, pp. 44-44
Open Access | Times Cited: 77
Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach
S.T.R. Moolamalla, Rami Balasubramanian, Ruchi Chauhan, et al.
Microbial Pathogenesis (2021) Vol. 158, pp. 105114-105114
Open Access | Times Cited: 68
Shift work is associated with positive COVID-19 status in hospitalised patients
Robert Maidstone, Simon Anderson, David Ray, et al.
Thorax (2021) Vol. 76, Iss. 6, pp. 601-606
Open Access | Times Cited: 59
Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc
Salvatore Corrao, Raffaella Mallaci Bocchio, Marika Lo Monaco, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1261-1261
Open Access | Times Cited: 59
A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19
Faheem Ahmed, Afaque Manzoor Soomro, Abdul Rahim Chethikkattuveli Salih, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113350-113350
Open Access | Times Cited: 58
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
Lin Wang, Yan Wu, Sheng Yao, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 4, pp. 788-796
Open Access | Times Cited: 57
Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action
Ana Muñoz-Jurado, Begoña M. Escribano, Javier Caballero‐Villarraso, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1569-1596
Open Access | Times Cited: 57
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology
George Anderson, Annalucia Carbone, Gianluigi Mazzoccoli
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1597-1597
Open Access | Times Cited: 45
Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
Kuoyuan Cheng, Laura Martin‐Sancho, Lipika R. Pal, et al.
Molecular Systems Biology (2021) Vol. 17, Iss. 11
Open Access | Times Cited: 40
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Rüssel J. Reiter, Ramaswamy Sharma, Fedor Šimko, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 35
Computational drug repurposing based on electronic health records: a scoping review
Nansu Zong, Andrew Wen, Sungrim Moon, et al.
npj Digital Medicine (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top